These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 30118769)

  • 1. Structure based identification and biological evaluation of novel and potent inhibitors of PCAF catalytic domain.
    Suryanarayanan V; Rajavel T; Devi KP; Singh SK
    Int J Biol Macromol; 2018 Dec; 120(Pt A):823-834. PubMed ID: 30118769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain.
    Suryanarayanan V; Singh SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4303-4319. PubMed ID: 29228881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of dual inhibition property of newly discovered inhibitors against PCAF and GCN5 through in silico screening, molecular dynamics simulation and DFT approach.
    Suryanarayanan V; Singh SK
    J Recept Signal Transduct Res; 2015; 35(5):370-80. PubMed ID: 25404235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.
    Chaikuad A; Lang S; Brennan PE; Temperini C; Fedorov O; Hollander J; Nachane R; Abell C; Müller S; Siegal G; Knapp S
    J Med Chem; 2016 Feb; 59(4):1648-53. PubMed ID: 26731131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of PCAF suppresses microglial-mediated β-amyloid neurotoxicity.
    Park SY; Lee YH; Seong AR; Lee J; Jun W; Yoon HG
    Int J Mol Med; 2013 Aug; 32(2):469-75. PubMed ID: 23740527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the binding mode and mechanistic insights of pentadecylidenemalonate (1b) as activator of histone acetyltransferase PCAF.
    Suryanarayanan V; Singh SK
    J Biomol Struct Dyn; 2019 Jun; 37(9):2296-2309. PubMed ID: 30044210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of activation mechanism and conformational stability of
    Sivanandam M; Manjula S; Kumaradhas P
    J Biomol Struct Dyn; 2019 Sep; 37(15):4006-4018. PubMed ID: 30301423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence polarization for the evaluation of small-molecule inhibitors of PCAF BRD/Tat-AcK50 association.
    Hu P; Wang X; Zhang B; Zhang S; Wang Q; Wang Z
    ChemMedChem; 2014 May; 9(5):928-31. PubMed ID: 24474698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule inhibitors of acetyltransferase p300 identified by high-throughput screening are potent anticancer agents.
    Yang H; Pinello CE; Luo J; Li D; Wang Y; Zhao LY; Jahn SC; Saldanha SA; Chase P; Planck J; Geary KR; Ma H; Law BK; Roush WR; Hodder P; Liao D
    Mol Cancer Ther; 2013 May; 12(5):610-20. PubMed ID: 23625935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
    Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
    Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding mechanism of anacardic acid, carnosol and garcinol with PCAF: A comprehensive study using molecular docking and molecular dynamics simulations and binding free energy analysis.
    Jaganathan R; Kumaradhas P
    J Cell Biochem; 2023 May; 124(5):731-742. PubMed ID: 36966470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of sumoylation activating enzyme 1 inhibitors by structure-based virtual screening.
    Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
    J Chem Inf Model; 2013 Apr; 53(4):809-20. PubMed ID: 23544417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimeric structure of p300/CBP associated factor.
    Shi S; Lin J; Cai Y; Yu J; Hong H; Ji K; Downey JS; Lu X; Chen R; Han J; Han A
    BMC Struct Biol; 2014 Jan; 14():2. PubMed ID: 24423233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones.
    Dekker FJ; Ghizzoni M; van der Meer N; Wisastra R; Haisma HJ
    Bioorg Med Chem; 2009 Jan; 17(2):460-6. PubMed ID: 19111471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
    Deniz U; Ozkirimli E; Ulgen KO
    J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing p300/CBP associated factor (PCAF)-dependent pathways with a small molecule inhibitor.
    Modak R; Basha J; Bharathy N; Maity K; Mizar P; Bhat AV; Vasudevan M; Rao VK; Kok WK; Natesh N; Taneja R; Kundu TK
    ACS Chem Biol; 2013; 8(6):1311-23. PubMed ID: 23570531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator.
    Liu X; Wang L; Zhao K; Thompson PR; Hwang Y; Marmorstein R; Cole PA
    Nature; 2008 Feb; 451(7180):846-50. PubMed ID: 18273021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of ERK1 gene expression by coactivator proteins.
    Chu BY; Tran K; Ku TK; Crowe DL
    Biochem J; 2005 Dec; 392(Pt 3):589-99. PubMed ID: 16050810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.